Stockreport

Reata Pharma up 11% on potential acquisition interest [Seeking Alpha]

Reata Pharmaceuticals, Inc. - Class A  (RETA) 
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.reatapharma.com
PDF Reata Pharmaceuticals ( RETA +10.9% AMGN -3.9% Reata's lead candidate is bardoxolone methyl, in late-stage development for a kidney disorder called Alport syndrome, conn [Read more]